 JournalPre-proof
HydroxychloroquineandazithromycinasatreatmentofCOVID-19:
resultsofanopen-labelnon-randomizedclinicaltrial
PhilippeGautret,Jean-ChristopheLagier,PhilippeParola,
VanThuanHoang,LineMeddeb,MorganeMailhe,
BarbaraDoudier,JohanCourjon,Val
´
erieGiordanengo,
VeraEstevesVieira,Herv
´
eTissotDupont,St
´
ephaneHonor
´
e,
PhilippeColson,EricChabri

ere,BernardLaScola,
Jean-MarcRolain,PhilippeBrouqui,DidierRaoult
PII:S0924-8579(20)30099-6
DOI:
https://doi.org/10.1016/j.ijantimicag.2020.105949
Reference:ANTAGE105949
Toappearin:
InternationalJournalofAntimicrobialAgents
Pleasecitethisarticleas:PhilippeGautret,Jean-ChristopheLagier,PhilippeParola,
VanThuanHoang,LineMeddeb,MorganeMailhe,BarbaraDoudier,JohanCourjon,
Val
´
erieGiordanengo,VeraEstevesVieira,Herv
´
eTissotDupont,St
´
ephaneHonor
´
e,
PhilippeColson,EricChabri

ere,BernardLaScola,Jean-MarcRolain,PhilippeBrouqui,
DidierRaoult,HydroxychloroquineandazithromycinasatreatmentofCOVID-19:resultsofan
open-labelnon-randomizedclinicaltrial,
InternationalJournalofAntimicrobialAgents
(2020),doi:
https://doi.org/10.1016/j.ijantimicag.2020.105949
ThisisaPDFofanarticlethathasundergoneenhancementsafteracceptance,suchastheaddition
ofacoverpageandmetadata,andformattingforreadability,butitisnotyettheversionof
record.Thisversionwillundergoadditionalcopyediting,typesettingandreviewbeforeitispublished
initsform,butweareprovidingthisversiontogiveearlyvisibilityofthearticle.Pleasenotethat,
duringtheproductionprocess,errorsmaybediscoveredwhichcouldaffectthecontent,andalllegal
disclaimersthatapplytothejournalpertain.
©
2020PublishedbyElsevierB.V.
                       